In the ever-evolving landscape of pharmaceuticals, biosimilars have emerged as game-changers. But with their rise comes a unique challenge: how […]
Biosimilar Naming: Navigating the Complex World of Biological Lookalikes Read Post »
How to Order the FDA Orange Book Historical copies of the FDA Orange Book archives are very potent tools for
In the complex world of healthcare economics, few topics generate as much debate and interest as drug pricing. As healthcare
Value-Based Drug Pricing: A Promising Yet Challenging Approach to Healthcare Reform Read Post »
The Pharmaceutical Landscape: A Delicate Balance In the complex world of healthcare, few topics spark as much debate as the
The Cost Of A Cure: Patent Rights And Drug Prices Read Post »
In the complex and often controversial world of pharmaceutical pricing, a $37,000-a-year medicine is emerging as an unexpected model for
How a $37,000-a-year medicine sets a good model for drug pricing Read Post »
Three Big Mistakes Drug Companies Make in Recruiting New Employees In the fast-paced world of biopharmaceuticals, recruiting top talent is
3 big mistakes drug companies make in recruiting new employees Read Post »
The biopharmaceutical industry stands at a crossroads. The era of blockbuster drugs, once the lifeblood of big pharma, is waning.
As blockbuster drugs fizzle, biotech looks warily to the next big thing Read Post »
File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food
By Dylan Scott, Posted with permission from STAT Mark Cuban has something to say about prescription drug prices. The billionaire
Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.
